Balaxi Pharmaceuticals
BALAXI · Retail > Trading · MD: Ashish Maheshwari · Listing date: Nov. 30, 2015 · Hyderabad · http://www.balaxiventures.in/

Stock Price vs Company Growth
1d
0.0%
1w
8.7%
1m
41.0%
3m
0.1%
6m
40.5%
1y
62.7%
5y
26.5%
10y
26.3%
all
23.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 24.9 0%
15.2
25.9
Company Overview

Sales
276 Cr
Growth: -2.6%
Profit after Tax
9.44 Cr
Growth: -34.9%
Micro Cap
138 Cr
P/E: 14.6x
Industry P/E: 24.6x
Fundamentals

Sales (Cr) ₹ 276
Growth -2.6%
EBITDA 7.6%
P/S 0.5x
Dividend 0.0%
P/E 14.6x
Book Value ₹ 31.7
PEG Ratio -5.6x
ROE 5.4%
P/B 0.8x
Shareholding Pattern

Institutions
Elara India Opportunities Fund Limited
9.5 %
Marshal Global Capital Fund Ltd
9.5 %
Amol Anand Mantri
1.73 %
Iepf
0.75 %
Promoters
Balaxi Overseas Private Limited
70.0 %
Ashish Maheshwari
1.81 %
Minoshi Maheshwari
1.06 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG productsHistory and Milestones2003-07Commenced Pharmaceutcal business by supplying white labeled products to customers in Africa.Sourcing was from WHO GMP certified plants based in India.2008-10Created frontend presence for its Pharmaceutical Business by setting up 1st wholesale depot in Angola in 2008.
Investors (20)
Followers (1)